All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAART-LX205 | Anti-TG (2C7) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | 2C7 | Human | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX206 | Anti-TG (VB5) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | VB5 | Human | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX207 | Anti-TG (3C42) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | 3C42 | Human | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX208 | Anti-TG (J8B45.5) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | J8B45.5 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX209 | Anti-TG (J8A32.13) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | J8A32.13 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX210 | Anti-TG (MH52) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | MH52 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX211 | Anti-TG (FI.1) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | FI.1 | Human | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX212 | Anti-TG (TI.1) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | TI.1 | Human | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX213 | Anti-TG (2C7) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | 2C7 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX214 | Anti-TG (VB5) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | VB5 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX215 | Anti-TG (3C42) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | 3C42 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX216 | Anti-TG (J8B45.5) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | J8B45.5 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX217 | Anti-TG (J8A32.13) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | J8A32.13 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX218 | Anti-TG (MH52) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | MH52 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX219 | Anti-TG (FI.1) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | FI.1 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX220 | Anti-TG (TI.1) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | TI.1 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION